{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-27",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 4
    }
  },
  "results": [
    {
      "discontinued_date": "04/15/2026",
      "update_type": "New",
      "initial_posting_date": "04/15/2026",
      "package_ndc": "0093-8076-56",
      "generic_name": "Tiagabine Hydrochloride Tablet",
      "contact_info": "888-838-2872",
      "related_info": "Discontinuation of the manufacture of the drug",
      "openfda": {
        "application_number": [
          "NDA020646"
        ],
        "brand_name": [
          "TIAGABINE HYDROCHLORIDE"
        ],
        "generic_name": [
          "TIAGABINE HYDROCHLORIDE"
        ],
        "manufacturer_name": [
          "Teva Pharmaceuticals USA, Inc."
        ],
        "product_ndc": [
          "0093-8076",
          "0093-5030",
          "0093-5031",
          "0093-8072"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "TIAGABINE HYDROCHLORIDE"
        ],
        "rxcui": [
          "1299903",
          "1299909",
          "1299911",
          "1299917"
        ],
        "spl_id": [
          "2a8d7987-54ae-45d7-8224-361dac37e0a4"
        ],
        "spl_set_id": [
          "953ef3cc-e3cb-480f-b9ea-256520fd62b8"
        ],
        "package_ndc": [
          "0093-5030-56",
          "0093-5031-56",
          "0093-8072-56",
          "0093-8076-56"
        ],
        "unii": [
          "DQH6T6D8OY"
        ]
      },
      "update_date": "04/15/2026",
      "therapeutic_category": [
        "Neurology"
      ],
      "dosage_form": "Tablet",
      "presentation": "Tiagabine Hydrochloride, Tablet, 16mg 30 count (NDC 0093-8076-56)",
      "company_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "To Be Discontinued"
    }
  ]
}